News
04-27-2011, 01:04 AM
Genomic Health, Inc. (Nasdaq: GHDX) announced the launch of RxPONDER S1007 (Rx for Positive Node, Endocrine Responsive Breast Cancer), a clinical trial being led by SWOG, one of the largest National Cancer Institute (NCI) supported cancer cooperative groups...
More... (http://www.medicalnewstoday.com/articles/223417.php)
More... (http://www.medicalnewstoday.com/articles/223417.php)